Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 9/20 | 0.39 |
| ▸ | ITGAV | P06756 | 9/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8912018 | 0.91 | ALDH1A1 (0.39) | NPSR1RAB9AALDH1A1 | |
| SCHEMBL8911896 | 0.90 | ATM (0.38) | NPSR1ALDH1A1 | |
| SCHEMBL8912045 | 0.89 | ALDH1A1 (0.43) | NPSR1ALDH1A1 | |
| SCHEMBL8911361 | 0.88 | NPSR1 (0.39) | NPSR1RAB9AALDH1A1 | |
| SCHEMBL8917887 | 0.87 | MAPT (0.40) | NPSR1RAB9AALDH1A1 | |
| SCHEMBL8913775 | 0.86 | ATM (0.50) | ITGB3ITGAV | |
| SCHEMBL8913766 | 0.86 | ATM (0.50) | ITGB3ITGAV | |
| SCHEMBL8911768 | 0.84 | ALDH1A1 (0.39) | NPSR1ALDH1A1 | |
| SCHEMBL8913843 | 0.84 | NPSR1 (0.36) | NPSR1RAB9AALDH1A1 | |
| SCHEMBL8913653 | 0.83 | ALDH1A1 (0.41) | RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0799230-A1 | THIENOXAZINONE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996019482-A1 | THIENOXAZINONE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 1996-06-27 | — | — | WO | disclosed |